Related references
Note: Only part of the references are listed.Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice
Ying Liu et al.
VACCINE (2011)
Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers
Dianna Rynkiewicz et al.
VACCINE (2011)
Distinct immune responses of recombinant plasmid DNA replicon vaccines expressing two types of antigens with or without signal sequences
Yun-Zhou Yu et al.
VACCINE (2010)
Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responses
Shuchi Midha et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Individual and bivalent vaccines against botulinum neurotoxin serotypes A and B using DNA-based Semliki Forest virus vectors
Yunzhou Yu et al.
VACCINE (2009)
The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate
Yun-Zhou Yu et al.
VACCINE (2009)
Current progress of DNA vaccine studies in humans
Shan Lu et al.
EXPERT REVIEW OF VACCINES (2008)
Plasmid-based vaccination with candidate anthrax vaccine antigens induces durable type 1 and type 2 T-helper immune responses
Yongxin Zhang et al.
VACCINE (2008)
DNA vaccines and their applications in veterinary practice: current perspectives
K. Dhama et al.
VETERINARY RESEARCH COMMUNICATIONS (2008)
Enhanced immune responses using plasmid DNA replicon vaccine encoding the Hc domain of Clostridium botulinum neurotoxin serotype A
Yun-Zhou Yu et al.
VACCINE (2007)
Human monocyte-derived dendritic cells express TLR9 and react directly to the CpG-A oligonucleotide D19
Victoria Hoene et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
DNA vaccines: Recent developments and future possibilities
Margaret A. Liu et al.
HUMAN GENE THERAPY (2006)
CpG oligodeoxynucleotides as DNA adjuvants in vertebrates and their applications in immunotherapy
Hso-Chi Chaung
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
Type I Interferons are essential for the efficacy of replicase-based DNA vaccines
Wolfgang W. Leitner et al.
VACCINE (2006)
Gene-based vaccines: recent technical and clinical advances
Jeffrey B. Ulmer et al.
TRENDS IN MOLECULAR MEDICINE (2006)
CpG-modified plasmid DNA encoding flagellin improves immunogenicity and provides protection against Burkholderia pseudomallei infection in BALB/c mice
YS Chen et al.
INFECTION AND IMMUNITY (2006)
Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors
C Coban et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Effects of multiple copies of CpG on DNA vaccination
AL Zhang et al.
DNA AND CELL BIOLOGY (2005)
Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1
EKL Nordström et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Immunostimulatory capacity of DNA vaccine vectors in porcine PBMC: a specific role for CpG-motifs?
T Verfaillie et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2005)
Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines
WW Leitner et al.
VACCINE (2004)
Methylated CpG-containing plasmid activates the immune system
S Cornélie et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2004)
CpG motifs are efficient adjuvants for DNA cancer vaccines
A Schneeberger et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities
J Vollmer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Use of CpG oligodeoxynucleotides as immune adjuvants
DM Klinman et al.
IMMUNOLOGICAL REVIEWS (2004)
Vaccine adjuvants: Current state and future trends
N Petrovsky et al.
IMMUNOLOGY AND CELL BIOLOGY (2004)
Enhanced cell-mediated IFN-γ-secreting activity against the HIV-1IIIBV3 peptide of the TAB9 multiepitope after DNA vaccine backbone engineering
EG Rodríguez et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells
NL Bernasconi et al.
BLOOD (2003)
Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions
JD Marshall et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-α induction in plasmacytoid dendritic cells
G Hartmann et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways
WW Leitner et al.
NATURE MEDICINE (2003)
Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A
JR Kirman et al.
INFECTION AND IMMUNITY (2003)
Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors
RA Pontarollo et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine
Y Kojima et al.
VACCINE (2002)
Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs
D Verthelyi et al.
JOURNAL OF IMMUNOLOGY (2001)
Antiviral protection after DNA vaccination is short lived and not enhanced by CpG DNA
S Oehen et al.
IMMUNOLOGY (2000)
Share Paper
